Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC
Clinical trial NCT04629781 · TERMINATED
Trial details
- NCT number
- NCT04629781
- Sponsor
- Swiss Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-28
- Primary completion
- 2024-01-29
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.